Serious Psychological Distress, Substance Use Disorders, and Social Issues Among Men and Women in the United States During the COVID-19 Pandemic
American Journal of Health Promotion · 2023
DOI: 10.1177/08901171231188187 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Health Promotion, 2023. Verfasst von Joy Gray und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Educational Psychology, Counseling, and Special Education College of Education, The Pennsylvania State University, University Park, PA,…. Hauptthemen laut MEDLINE: COVID-19, Substance-Related Disorders, Psychological Distress. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDA NIH HHS, National Institutes of Health, National Institute on Drug Abuse.
Abstract (Originalsprache)
Purpose
This study assesses the association between SUD, economic hardship, gender, and related risk and protective factors on serious psychological distress (SPD) during the COVID-19 pandemic.
Design
Quantitative cross-sectional design.
Setting
National Survey on Drug Use and Health (NSDUH). Sample Data were from the NSDUH (2020) N = 25,746, representing 238,677,123 US adults, who identified as 18 or older and either male or female. Measures SPD measured as scoring a 13 or more on the Kessler (K6) distress scale. SUDs were determined using DSM5 criteria. Sociodemographic and socioeconomic variables included in analyses. Analysis Logistic regressions evaluated the association between gender, protective, and risk factors on SPD.
Results
After controlling for sociodemographic and related factors of SPD, having a SUD was the strongest correlate of SPD. Other significant correlates of SPD included female gender and an income level at or below the federal poverty threshold. Gender stratified regressions illustrated that religiosity, self-identifying as Black, and high levels of education were protective against SPD for women but not men. Poverty level was more associated with SPD for women than men.
Conclusion
In the United States, individuals with SUDs were nearly four times more likely to report SPD than those without SUDs, controlling for economic hardship and markers of social support during 2020. Effective social interventions to reduce SPD among individuals with SUDs are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Educational Psychology, Counseling, and Special Education College of Education, The Pennsylvania State University, University Park, PA, USA.
- Department of Human Development and Family Studies, The Pennsylvania State University, University Park, PA, USA.
- Simches Division of Child and Adolescent Psychiatry, McLean Hospital, Belmont, MA, USA.
- Consortium on Substance Use and Addiction, The Pennsylvania State University, University Park, PA, USA.
ORCID-Profile: Joy Gray
Förderung
- NIDA NIH HHS
- National Institutes of Health
- National Institute on Drug Abuse
Zitieren
APA
Gray, J., Santos-Lozada, A. R., Hard, G., Apsley, H., O'Sullivan, D., & Jones, A. A. (2023). Serious Psychological Distress, Substance Use Disorders, and Social Issues Among Men and Women in the United States During the COVID-19 Pandemic. American Journal of Health Promotion. https://doi.org/10.1177/08901171231188187
Vancouver
Gray J, Santos-Lozada AR, Hard G, Apsley H, O'Sullivan D, Jones AA. Serious Psychological Distress, Substance Use Disorders, and Social Issues Among Men and Women in the United States During the COVID-19 Pandemic. American Journal of Health Promotion. 2023. doi:10.1177/08901171231188187
BibTeX
@article{Gray2023,
author = {Gray, Joy and Santos-Lozada, Alexis R and Hard, Greg and Apsley, Hannah and O'Sullivan, Deirdre and Jones, Abenaa A},
title = {Serious Psychological Distress, Substance Use Disorders, and Social Issues Among Men and Women in the United States During the COVID-19 Pandemic},
journal = {American Journal of Health Promotion},
year = {2023},
doi = {10.1177/08901171231188187}
}
EUVIMED